StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly non-GAAP diluted earnings per share ($) ($)

Form 8-K Non-GAAP Reconciliation Schedules

QuarterlyAnnual
Latest, Q2 2026
8.38
Period ended Jun 30, 2026
Change on a year earlier
+32.8%
6.31 in Q2 2025
History
37 quarters
Since Q4 2016
Sources
30
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP diluted earnings per share ($) ($)Year on yearSource
Q2 2026Jun 30, 20268.38+32.8%Earnings Release (Form 8-K FY2026Q2 EX-99.1) (filed 2026-08-05) ↗
Q1 2026Mar 31, 20268.55+156.0%Earnings Release (Form 8-K FY2026Q1 EX-99.1) (filed 2026-04-30) ↗
Q4 2025Dec 31, 20257.54+41.7%Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Q3 2025Sep 30, 20257.02+494.9%Earnings Release (Form 8-K FY2025Q3 EX-99.1) (filed 2025-10-30) ↗
Q2 2025Jun 30, 20256.31+61.0%Earnings Release (Form 8-K FY2025Q2 EX-99.1) (filed 2025-08-07) ↗
Q1 2025Mar 31, 20253.34+29.5%Earnings Release (Form 8-K FY2025Q1 EX-99.1) (filed 2025-05-01) ↗
Q4 2024Dec 31, 20245.32+113.7%Earnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 20241.18+1,080.0%Earnings Release (Form 8-K FY2024Q3 EX-99.1) (filed 2024-10-30) ↗
Q2 2024Jun 30, 20243.92+85.8%Earnings Release (Form 8-K FY2024Q2 EX-99.1) (filed 2024-08-08) ↗
Q1 2024Mar 31, 20242.58+59.3%Earnings Release (Form 8-K FY2024Q1 EX-99.1) (filed 2024-04-30) ↗
Q4 2023Dec 31, 20232.49+19.1%Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 20230.10-94.9%Earnings Release (Form 8-K FY2023Q3 EX-99.1) (filed 2023-11-02) ↗
Q2 2023Jun 30, 20232.11+68.8%Earnings Release (Form 8-K FY2023Q2 EX-99.1) (filed 2023-08-08) ↗
Q1 2023Mar 31, 20231.62-38.2%Earnings Release (Form 8-K FY2023Q1 EX-99.1) (filed 2023-04-27) ↗
Q4 2022Dec 31, 20222.09-16.1%Earnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 20221.98+2.1%Earnings Release (Form 8-K FY2022Q3 EX-99.1) (filed 2022-11-01) ↗

Cite this data

StockData. (2026). Eli Lilly Non-GAAP diluted earnings per share ($) ($), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/eps_nongaap

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.